EtQ re-certified to ISO specifications

EtQ (Farmingdale, New York) reported that its development center has been re-certified to ISO 9001:2008 certification, after an extensive audit conducted by Soci t G n rale de Surveillance (SGS).

EtQ's development center is responsible for the development of software platforms and application suites to achieve and maintain compliance with quality, environmental, and health and safety management system requirements.

EtQ is an Enterprise Quality and Compliance Management software for identifying, mitigating, and preventing high-risk events through integration, automation, and collaboration.

Interleukin Genetics meets Amex standards

Interleukin Genetics (Waltham, Massachusetts) said that the Corporate Compliance Staff of the NYSE Amex LLC has accepted the company's plan to meet the Exchange's continued listing standards, and has granted the company an extension to become compliant, through Dec. 31, 2009. As a result of the staff extension, the company was not required to attend a hearing before the Listing Qualifications Panel.

"We are pleased with the decision by the Exchange to continue our listing and look forward to meeting the business goals established by the company in our plan," said Lewis Bender, CEO, Interleukin Genetics. "The decision provides us with a reasonable timeline to achieve our objectives and become compliant with the listing standards. We look to execute on our business strategy and establish our leadership in the personalized health industry."